Archives — November 2017 back to current month (67)

Potential Alzheimer's Therapies Focus on Early Intervention (11/30/2017)

After attending a conference on the latest in development of Alzheimer's disease treatments, Andrew Fein, an analyst with H.C. Wainwright & Co., provided an industry update.

more>

Bitcoin, Cryptocurrency and Blockchain... the New Digital Economy (11/29/2017)

The exploding price of bitcoin has ushered in a new cryptocurrency ecosystem, says Michael Sheikh of Falcon Strategic Research, who decodes the bitcoin world order for investors.

more>

Analysts Say Medical Device Firm Sees Record Quarterly Revenue Growth, 120% YOY (11/29/2017)

Following the company's release of its latest financial report, three analysts weighed in on the results.

more>

Revenue Growth of 163% for Internet Accessibility Firm, Gains Social Security Administration as Client (11/29/2017)

A company that brings accessibility to the Internet has been experiencing rapid growth.

more>

Development Agreement for Permian Basin Acreage Would Eliminate Capex Budget (11/28/2017)

The letter of intent signed to develop this oil & gas company's large acreage in the red-hot Permian Basin would not only eliminate the company's capex budget, it could give the company a long-term cash flow stream.

more>

Oil & Gas Company Has 'High-Impact Exploration Potential' (11/28/2017)

Bill Newman, an analyst with Mackie Research Capital Corp., shared this energy firm's Q3/17 news.

more>

Battery Production More than a Tesla Nightmare (11/28/2017)

Battery metals are in short supply as companies race to build EVs and energy storage system, says Ron Struthers of Struthers Resource Stock Report. He surveys the field and profiles one company he believes could be a new LIB anode supplier.

more>

Pan American Silver Buys 16% of Silver Explorer (11/27/2017)

A potentially large silver project in Bolivia has caught the attention of Pan American Silver.

more>

Jack Chan's Weekly Precious Metals Market Update (11/27/2017)

Technical analyst Jack Chan charts the latest movements in the gold and silver markets.

more>

Bullion Bank Short-Covering Will Become Year-End Profit-Taking (11/27/2017)

Precious metals expert Michael Ballanger discusses why junior gold and silver explorers have been underperforming the lithium and base metals explorers.

more>

An Unconventional Lithium Play with Vast Potential (11/26/2017)

The Critical Investor profiles a company with U.S. lithium assets that has drill results coming out in the next few weeks, with the potential for a large resource.

more>

Cheap Permian Driller Has Big Upside (11/26/2017)

Technical analyst Clive Maund of CliveMaund.com discusses a Permian driller that he believes is an "attractive speculative play."

more>

The Big Picture for Gold (11/24/2017)

Rudi Fronk and Jim Anthony, cofounders of Seabridge Gold, explain the "Potent Director Fallacy," and describe what this belief system means for gold and other markets.

more>

The Future of Mining: Urban Mining (11/23/2017)

Technical analyst Clive Maund of CliveMaund.com profiles a company that has developed a pollution-free process for extracting gold and base metals from E-waste.

more>

Consumer Demand for 'Green' Packaging Driving This Company's Rapid Growth (11/21/2017)

A Vancouver-based company is making its mark on the rapidly expanding bioplastics sector.

more>

Pure-Play Vanadium Producer's Q3 Revenues Increase 153% YOY (11/21/2017)

With the price of vanadium on the rise, one pure-play producer is reaping the benefits.

more>

Home Cooking Fires Four Times More Likely on Thanksgiving, But This 'Undervalued' Company Aims to End That (11/21/2017)

A company that has products that prevent home cooking fires has one analyst calling it an "undervalued and underfollowed play on new safety requirements."

more>

Expert's Opinion: 'Back Up the Truck' for this Stock (11/21/2017)

Ron Struthers of Struthers' Resource Stock Report takes a look at results from two mining companies, and picks the one he considers a winner.

more>

Recovering Residential Market Bodes Well for Building Products (11/21/2017)

Russell Stanley, an analyst with Echelon Wealth Partners, provided a review of this hardwood lumber wholesaler.

more>

Streamlining of U.S. Environmental Permits Could Benefit Nevada Mine Developer (11/21/2017)

As this company moves closer to bringing a mine into production, a U.S. Department of the Interior decision could help derisk the project.

more>

Why the Commodity Supercycle Is Favoring Investors Right Now (11/21/2017)

Precious, base and energy metals are all benefiting from the commodity supercycle, says Louis James, editor of International Speculator, who also discusses his Golden Runway theory of price appreciation and talks about a handful of companies that he believes are on the rise.

more>

Analyst's 'Top Pick' Advances Vaccine Candidates (11/21/2017)

Douglas Loe, an analyst with Echelon Wealth Partners, provided an update on this biotech's platform pipeline targeting ovarian and blood cancers, as well as respiratory syncytial virus.

more>

Low-Cost Oil & Gas Player in High-Rent Permian Basin (11/21/2017)

An oil E&P company has acquired rights at low cost in the prolific Permian Basin that it is now exploring and producing.

more>

Jack Chan's Weekly Precious Metals Market Update (11/20/2017)

Technical analyst Jack Chan charts the latest movements in the gold and silver markets.

more>

Oil Charts Showing Extreme Paradoxes (11/20/2017)

Technical analyst Clive Maund discusses the conflicting signals from oil's price chart and from the COT and Hedgers' charts.

more>

Holding on Companies in Gold and Silver, and a Food Multinational (11/20/2017)

The news from three companies has prompted updates from Adrian Day of Adrian Day Asset Management.

more>

Stock Price Jump Reflects Biotech's Active October (11/20/2017)

This immunotherapy firm's stock recently doubled its Nov. 7 price following lots of news, including a clinical data release, a trial launch and an executive appointment.

more>

Maxim's Target Price on Biotech Makes It More Than a Tenbagger (11/20/2017)

Jason Kolbert, an analyst with Maxim Group, provided an update on this biopharmaceutical firm's two recently acquired oncology assets.

more>

'Hot' Alzheimer's Market is Promising for Biotech with 'Novel' Drug Candidate (11/20/2017)

André Uddin, an analyst with Mackie Research Capital Corp., summarized the quarterly financial results and anticipated catalysts for this Alzheimer's drug developer.

more>

Gold in Contradictory Position (11/19/2017)

The signals for gold are mixed, says technical analyst Clive Maund, who delves into the ramifications.

more>

Technical Analyst Sees Weakness in Silver (11/19/2017)

Technical analyst Clive Maund charts silver and finds the signals contradictory.

more>

'Explorer of the Year' Recipient Convincingly Updates Resource in a Booming Zinc Market (11/17/2017)

The Critical Investor profiles a company exploring a high-grade zinc property, and explains why he believes the upcoming PEA could surprise markets.

more>

AgriTech Company Sells to Organic and Cannabis Markets (11/16/2017)

The company's soon-to-be-announced prefeasibility study will evaluate expansion plans.

more>

Could Your Car Be Hacked? This Micro-Cap May Have the Solution (11/16/2017)

The many computer connections in cars make them vulnerable to hacking, says Michael Sheikh, founder of Falcon Strategic Research, who profiles a small company whose software takes a radically different approach to cybersecurity.

more>

Three Resource Companies; One Good Buy (11/16/2017)

Adrian Day of Adrian Day Asset Management reviews the current news and prospects at three resource companies, and comes up with at least one good buy.

more>

Streaming Company's 'Attractive Valuation' Is Behind Analyst's Outperform Rating (11/16/2017)

BMO Capital Markets reviewed this company's Q3/17 financial results and an impending deadline pertaining to one of its streams.

more>

Biotech's Target Price Increased as Shares 'Deeply Undervalued' (11/15/2017)

Wedbush analyst Robert Driscoll provided an update on the lead asset of this drug developer targeting cancer.

more>

Biotech Targets 'Blockbuster' Markets; Less-Addictive Opioid Painkiller Set for FDA Filing (11/15/2017)

Medical Technology Stock Letter editor John McCamant outlines the reasons behind the buy rating and target price increases for a company that, in addition to developing an alternative to addictive opioids for pain relief, has candidates targeting multiple immune disorders and cancer.

more>

The Holiday Season Comes Early After an Updated PEA Brings In a Bundle Full of Buy Ratings for Precious Metals Explorer (11/14/2017)

Five analysts explain why "several significant improvements" led to their Buy recommendations and highlight what investors need to know.

more>

The Lowdown on Getting High in Canada (11/14/2017)

Some 600 tonnes of marijuana a year are up for grabs as Canada moves to legalize weed, says Rick Mills, founder of Ahead of the Herd, who puts forth his case on why cannabis stocks should be in every investor's portfolio.

more>

Zinc's Rise Shines a Light on Pure-Play Producers and Explorers (11/13/2017)

With the price of zinc rising, investors are taking a second look at producers and explorers.

more>

Analyst Says Biotech Share Price Could Potentially 'Double' (11/13/2017)

Analyst Grant Zeng of Zacks Small Cap Research examines what transpired with this biopharmaceutical company during Q3/17.

more>

Biotech with Solid Pipeline and 'Solid Partnership Outlook' (11/13/2017)

Analyst Kevin DeGeeter, with Ladenburg Thalmann, relayed the highlights from his recent meeting with this company's management team about near-term clinical news and pipeline plans.

more>

Uranium Production Cuts 'Very Positive' for Market (11/13/2017)

Rob Chang, an analyst with Cantor Fitzgerald, discussed how one uranium company's upcoming facility closures should affect the market.

more>

Two 'Low-Risk' Gold Companies Present Opportunities to Buy and Hold (11/13/2017)

In his latest dispatch, Adrian Day of Adrian Day Asset Management reflects on the prospects and performance of a pair of gold companies.

more>

Gold and Base Metal Companies Are on This Expert's Shopping List (11/11/2017)

Adrian Day of Adrian Day Asset Management reports on news at three resource companies, calling each company "different" and "on the shopping list." 

more>

Jack Chan's Weekly Precious Metals Market Update (11/11/2017)

Technical analyst Jack Chan charts the latest moves in the gold and silver markets.

more>

Gold Producer Posts Q3 Beat on Lower Costs (11/09/2017)

BMO Capital Markets reported the Q3/17 financial and operating results for this international, mid-tier gold miner.

more>

Analyst Initiates on 'Potential Tenbagger' Oil & Gas Company (11/08/2017)

Bill Newman, an analyst with Mackie Research Capital Corp., explained how this energy firm could deliver substantial upside.

more>

Yukon Gold Project Now in Full Construction Mode (11/07/2017)

Construction is ramping up rapidly at this Yukon mine that one analyst calls a "strategic asset."

more>

Precious Metals Company Shows 'A Good Start' to New Fiscal Year (11/07/2017)

BMO Capital Markets reported the Q1/18 financial results of this streaming and royalty corporation.

more>

Two Uranium Firms Transact a Deal for Wyoming Asset (11/07/2017)

The sale of a uranium asset in Wyoming was announced on Nov. 2.

more>

Why Litecoin Is Massively Undervalued vs. Bitcoin (11/07/2017)

Cybercurrencies have been red-hot recently and Jason Hamlin of Gold Stock Bull explains why he believes Litecoin is undervalued.

more>

Biotech Reports Positive Topline Data; Biologics License Application in Progress (11/06/2017)

Ram Selvaraju, an analyst with H.C. Wainwright & Co., reviewed the recent clinical trial results released by this developer of cell therapies targeting oncology and orphan indications.

more>

Target Price Raised on 'Undervalued' Antibiotics Developer (11/06/2017)

Analyst Ed Arce discussed the rationale behind H.C. Wainwright & Co.'s decision to revise its models on this clinical-stage biopharmaceutical company.

more>

Could a FDA Warning Letter Provide a Silver Lining to This Home Care Medical Device Company? (11/06/2017)

Maj Soueidan, cofounder of GeoInvesting, profiles his long history with a company providing medical devices for the home care market.

more>

Hypocrisy Most Foul. . . (11/06/2017)

Precious metals expert Michael Ballanger examines why gold and silver have been stagnant while bitcoin and blockchains have taken off.

more>

Portfolio Review on Two Major Gold Companies and a Renewable Energy Company with a Purchase Offer (11/06/2017)

Adrian Day of Adrian Day Asset Management discusses three companies in his portfolio: one renewable energy company and two precious metal companies.

more>

Metalla Royalty & Streaming: The Way to Play Gold and Silver? (11/06/2017)

Peter Epstein of Epstein Research interviews the newly appointed chairman of Metalla Royalty and Streaming, Lawrence Roulston, for an update on the company.

more>

Data Analytics Gaining Traction (11/05/2017)

Ron Struthers of Struthers' Resource Stock Report delves into two rapidly growing data analytics companies.

more>

Jack Chan's Weekly Precious Metals Market Update (11/04/2017)

Technical analyst Jack Chan charts the latest moves in the gold and silver markets.

more>

Oil Poised to Break Key Resistance (11/03/2017)

Technical analyst Clive Maund describes the ways in which oil is positioned to rally.

more>

Company Returning to Brazil's Gold Rush Region Determined to Find the Source (11/02/2017)

A company with a gold project in the heart of Brazil's gold country has completed a reverse takeover and begins trading today on the TSX Venture Exchange.

more>

Coverage Initiated on Solar Power Firm with 'Strong Backlog Powering Rapid Growth' (11/02/2017)

Analyst Pardeep Sangha with Haywood Securities explained the investment thesis for this provider of solar power projects to the commercial market.

more>

Drug Offers 'Best-in-Class' Potential (11/01/2017)

John McCamant, editor of the Medical Technology Stock Letter, initiated coverage on a company that he calls an emerging leader in women's health.

more>

Big Biotech's Value Is Bolstered by Focus on Alzheimer's Disease (11/01/2017)

An analysis of this company's quarterly update highlights a pipeline studded with candidates targeting neurological indications.

more>

Sexy LEXI, a Lithium Brine Beauty in Argentina (11/01/2017)

Peter Epstein, founder of Epstein Research, profiles a company with prime land in the heart of the Lithium Triangle.

more>

More Archives

2017Nov Oct Sep Aug Jul Jun May Apr Mar Feb Jan

2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2015Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2014Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2013Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2012Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports Newsletter Free

A valid email address is required to subscribe